Wedbush Downgrades Cerulean Pharma (CERU) to Neutral
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Wedbush earlier downgraded Cerulean Pharma (NASDAQ: CERU) from Outperform to Neutral with a price target of $1.00 (from $9.00).
Shares of Cerulean Pharma closed at $2.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
- Jefferies Reiterates Buy on PPG Industries (PPG) - PT to $113
- UPDATE: Stifel Downgrades SL Green Realty (SLG) to Hold
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!